• NASDAQ

イルミナ

ILMN医療関連
141.07
  • 15分ディレイ株価

イルミナの掲示板の投稿コメント詳細

Billionaire activist Carl Icahn is preparing a proxy fight at Illumina Inc (NASDAQ: ILMN), saying the company went ahead with the controversial acquisition of Grail Inc despite opposition from regulators, costing shareholders $50 billion.

According to the letter viewed by Wall Street Journal, the activist plans to nominate three people to the company's board.

Mr. Icahn accuses Illumina of overpaying for a business that made "exactly zero dollars in revenue," then closing the deal despite regulatory hiccups.

He writes that holding on to Grail is costing Illumina $800 million annually, and that it faces a significant tax bill if ultimately forced to divest it.

Illumina was valued at over $70 billion in 2021, but currently, the company has lost over 50% of its value to around $30 billion as the Grail deal remains in limbo while the company faces heightened competition from lower-cost rivals.

返信

投資の参考になりましたか?

【PR】堅調な伸びを続ける「米国株」について学ぼう!高配当などおすすめ銘柄や選び方は? - マネックス証券 - Yahoo!ファイナンス
米国株の投資信託を探す

最近見た銘柄

最近見た銘柄はありません

JASRAC許諾番号
9008249113Y38200